Bob Lechleider

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ.

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

SVB Leerink Holdings LLC operates as an investment bank holding company with interest in investment services. The firm provides equity research, institutional sales and trading, corporate finance and strategic advisory services. The company was founded in 1995 and is headquartered in Boston, MA.

Boxer Capital LLC (Boxer Capital) is a venture capital subsidiary of Tavistock Group, Inc. founded in 2005 by Chris Fuglesang and Aaron I. Davis. The firm is headquartered in San Diego, California.

Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach.

The Austin Chamber of Commerce is an organization that helps people in the region achieve greater prosperity by working with businesses looking to create or expand their presence in the Austin region and help them create more jobs. The non-profit company is based in Austin, TX. The company has helped bring more than 400,000 jobs to the region since 2004 and take on the biggest challenges so businesses can focus on growing. Laura Huffman has been the CEO of the company since 2020.

Austin Technology Incubator is a deep tech incubator affiliated with the University of Texas at Austin. The non-profit company is based in Austin, TX. The company's mission is to empower university and community entrepreneurs through a customized approach to effectively commercialize their breakthrough innovations and compete in the marketplace. The company is committed to supporting deep tech solutions that will become the future for today's challenges. It was founded in 1989 and is the longest active technology incubator in Austin. The company was founded by Tab Ebrahim, Robert Norman Neville, Bart Bohn.

Pecan Street, Inc. is a non-profit company that conducts research on water and energy. The company is based in Austin, TX.

Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom.

Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford.

Research Bridge Partners (Research Bridge Partners) is a venture capital firm founded in 2016 by Reid Hoffman. The firm is headquartered in Austin, Texas.

Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN.

Just Another Acquisition Corp. operates as a blank check company. It was formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in New York, NY.

Eradivir, Inc. is a company that builds targeted therapeutics for infectious diseases. Eradivir spun out of a multi-year research and technology development program in Philip Low's lab in 2020. The company is based in West Lafayette, IN. The company has developed a universal platform against influenza and is now applying these technologies to SARS-CoV-2, the virus that causes COVID-19. The company was founded by Philip S. Low and Martin R. Low.

MorphImmune, Inc. is a biotechnology company that specializes in developing targeted oncology therapeutics. MorphImmune is based in West Lafayette, IN and has been led by CEO Clay B. Siegall since 2023. The company's proprietary targeted effector platform delivers payloads to diseased cells, reducing toxicity and increasing efficacy of known effector molecules. The company was founded on the research of Philip S. Low, Ph.D., the Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry at Purdue University.

Rocket Global Acquisition Corp. operates as a blank check company. The firm was formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was incorporated on February 9, 2021 and is headquartered in New York, NY.

Gennao Bio, Inc. is a privately-held genetic medicines company that is developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing its proprietary gene monoclonal antibody (gmab) platform technology. The company is based in Pennington, NJ. The company's gmab technology uses a novel, cell-penetrating antibody to non-covalently bind to, and deliver therapeutic levels of a wide variety of nucleic acid payloads, to select cells. Gennao Bio is initially focusing on addressing significant unmet needs in oncology and rare monogenic skeletal muscle diseases. The company's non-viral delivery platform offers significant advantages over traditional gene delivery systems as it can deliver multiple types of nucleic acids, allows for repeat dosing and dose optimization, and can be easily and affordably manufactured. The company was founded in 2020 by Bruce Turner, Elias Quijano, Peter M. Glazer, Stephen P. Squinto. Christopher M. Duke has been the CEO of the company since 2021.

Hydrobuilder Holdings LLC is a leading omnichannel platform in the hydroponics, CEA, and specialty agriculture industry. The private company is based in the United States, with a retail footprint in four states and commercial warehouse direct capabilities in 17 states. The American company serves a wide range of customers, from hobbyists to large commercial growers, through its online, retail, and warehouse direct channels. These companies include Greencoast, Hydrobuilder.com, Elevated Equipment and Supply, and Way to Grow. Hydrobuilder Holdings was founded in October 2020 and has acquired four market-leading companies across different sales channels and geographies. The CEO of Hydrobuilder Holdings is Markus Alan Hockenson.

Enavate Sciences is a platform created by Patient Square Capital to support therapeutic companies in advancing medicines and enabling technologies to address patient needs. The company is based in Delaware. Enavate strives to empower a diverse portfolio of therapeutic companies to accelerate innovation through capital support and operational experience. James P. Boylan has been the CEO of the American company since 2022.

Zenas Pharma, Inc. is an American pharmaceutical company that is focused on developing a portfolio of first- and autoimmune therapeutics to address areas of high unmet medical need. The company is located in the US. The company's lead product candidate, obexelimab (zb012), is a novel bifunctional antibody with first-in-class potential that inhibits B-cell lineages that express CD19.

Tetricus Labs is a company that develops a platform for patients to manage their own care. The company is based in New Haven, NY. The company was founded in 2022 by Sean McCurdy, Phil Corlett, Lindsay Dow. Lindsay Dow has been the CEO since 2022.